Sandra Rojas-Caro - Concepedia

Author

Sandra Rojas-Caro

Also Known As

S. Rojas-Caro, Sandra Rojas-Caro

Publications

610

Citations

H-Index

Concepts

All Affiliations

Sandra Rojas-Caro is an author at Synageva BioPharma (United States) specializing in translational medicine, pathology, and medicine.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	22
2	Pathology	1	1	22
3	Autoimmune Disease	1	1	22
4	Immunodeficiencies	1	1	22
5	Lysosomal Storage Disease	1	1	22

Sandra Rojas-Caro

Publications

577

Citations

H-Index

Page 1

	Year	Citations
A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency Barbara K. Burton, Manisha Balwani, François Feillet, New England Journal of Medicine	2015	238
The G0/G1 switch gene 2 is a novel PPAR target gene Fokko Zandbergen, Stéphane Mandard, Pascal Escher, Biochemical Journal	2005	232
Survival in infants treated with sebelipase Alfa for lysosomal acid lipase deficiency: an open-label, multicenter, dose-escalation study Simon Jones, Sandra Rojas-Caro, Anthony Quinn, Orphanet Journal of Rare Diseases	2017	85
Final results of the phase 1/2, open-label clinical study of intravenous recombinant human N-acetyl-α-d-glucosaminidase (SBC-103) in children with mucopolysaccharidosis IIIB Chester B. Whitley, Suresh Vijay, Bert Yao, Molecular Genetics and Metabolism Phase 1/2Translational MedicineMucopolysaccharidosis IiibAutoimmune DiseaseMedicine	2018	22

Page 1